Melanin pigments and melanosomal proteins as differentiation markers unique to normal and neoplastic melanocytes

Journal of Investigative Dermatology

Volumn 100, Issue 3 SUPPL., 1993, Pages

  Jimbow, Kowichi ^a   Lee, Simon K ^a   King, Michael G ^a   Hara, Hiroyuki ^a   Chen, Hua ^a   Dakour, Jamal ^a   Marusyk, Halyna ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

ANIMAL TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MELANOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN TUMOR;

ANIMAL; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; HUMAN; MELANINS; MELANOCYTES; MELANOMA; PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0027506198     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.1993.47     Document Type: Article

References (57)

1. K. Jimbow T.B. Fitzpatrick W.C. Quevedo Jr. Formation, chemical compositions and functions of melanin pigments in mammals Matoltsy Biology of the Integument, Vol. 2 1986 Springer-Verlag New York 278 296
2. W.H. Clark Jr. D.E. Elder D. Guerry IV A study of tumor progression The precursor lesion of superficial spreading and nodular melanomas. HumPathol 15 1984 1147 1165
3. A. Breslow Tumor thickness, cross-sectional areas, and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 92 1970 902 908
4. D.J. Reuiter G.N.P. van Buijen H. van Nouhuys S. Feroone Immuno-pathology of melanoma with monoclonal antibodies S. Ferrone Human Melanoma 1990 Springer-Verlag New York 253 277
5. K. Jimbow M. Jimbow V. Paetkau Analysis of human melanosome specific antigen (HMSA) in malignant melanoma and its precursors. Immunological aspects of human melanoma S. Ferrone Human Melanoma 1990 Springer Verlag New York 31 50
6. P.C. Nowell The clonal evolution of tumor all populations. Acquired genetic liability permits step wise selections of variant sublines and lines, tumour progression Science 194 1976 23 28
7. M. Jimbow H. Kanoh K. Jimbow Characterization of biochemical properties of melanosomes for structural and functional differentiation; analysis of the compositions of lipids and proteins in melanosomes and their subfractions J Invest Dermatol 79 1982 97 102
8. K. Jimbow Y. Miyake K. Honma K. Yasuda Y. Izumi A. Tsutsumi S. Ito Characterization of melanogenesis and morphogenesis of melanosomes by physico-chemical properties of melanin and melanosomes in malignant melanoma Cancer Res 44 1984 1128 1134
9. G. Prota Recent advances in the chemistry of melanogenesis in mammals J Invest Dermatol 75 1980 122 127
10. S. Ito Y. Imai K. Jimbow K. Fujita Incorporation of sulfhydryl compounds into melanins in vitro Biochim Biophys Acta 964 1988 1 7
11. S. Ito K. Jimbow Quantitative analysis of eumelanin and pheomelanin in hair and melanomas J Invest Dermatol 80 1983 268 273
12. K. Jimbow O. Ishida S. Ito Y. Hori C.J. Witkop Jr. R.A. King Combined chemical and electron microscopic studies of pheomelanosomes in human red hair J Invest Dermatol 81 1983 506 511
13. T.G. Salopek K. Yamada S. Ito K. Jimbow Dysplastic melanocytic nevi contain high levels of pheomelanin: quantitative comparison of pheomelanin/eumelanin levels between normal skin, common nevi and dysplastic nevi Pigm Cell Res 4 1991 172 179
14. I.A. Menon S. Persad N.S. Ranadive H.A. Haberman Effects of ultraviolet–visible irradiation in the presence of melanin isolated from human black or red hair upon Ehrlich ascites carcinoma cells Cancer Res 43 1983 3165 3169
15. Z.P. Harsanyi P.W. Post J.P. Brinkmann M.R. Chedekel R.M. Deibel Muta-genicity of melanin from human red hair Experientia 36 1980 291 292
16. W.H. Koch M.R. Chedekel Photoinitiated DNA damage by melanogenic intermediates in vitro Photochem Photobiol 44 1986 703 710
17. E.J. Land A. Thomson T.G. Truscott K.V. Subarao M.R. Chedekel Photochemistry of melanin precursors: Dopa, 5-S-cysteinyldopa and 2,5-S S-dicysteinyldopa. Photochem Photobiol 44 1986 697 702
18. N.S. Ranadive S. Shirwadkar S. Persad I.A. Menon Effects of melanin-induced free radicals on the isolated rat peritoneal mast cells J Invest Dermatol 86 1986 303 307
19. H. Takahashi T. Horikoshi K. Jimbow Fine structural characterization of melanosomes in dysplastic nevi Cancer 56 1985 111 123
20. P.J. Smith M.H. Greene D. Adams M.C. Paterson Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma Carcinogenesis 4 1983 911 916
21. M.I.R. Perera K.I.I. Um M.H. Greene H.L. Waters A. Brederg K.H. Kraemer Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility Cancer Res 46 1986 1005 1009
22. K. Jimbow T.G. Salopek W.T. Dixon G.E. Searles K. Yamada The epidermal melanin unit in the pathophysiology of malignant melanoma AmJ Dermatopathol 13 1991 179 188
23. J. Duchon B. Matous S. Pavel Melanogenuria M. Seiji Pigment Cell 1981: Phenotypic Expression in Pigment Cells 1981 Tokyo University Press Tokyo 609 615
24. H. Rorsman E. Rosengren Biosynthesis of melanin T.B. Fitzpatrick M.M. Wick K. Toda Brown melanoderma 1988 University of Tokyo Press Tokyo 63 74
25. H. Takahashi T.B. Fitzpatrick Quantitative determination of dopa; its application to measurement of dopa in urine and in the assay of tyrosinase in serum J Invest Dermatol 42 1964 161 165
26. M.L. Hohees Urinary excretion of dopa and metabolites by patients with melanoma Cancer 26 1970 146 169
27. M.J. Brown C.T. Dollery A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA) Plasma dopa may be the precursor of urine free dopamine. Br J Clin Pharmacol 1 1981 79 83
28. I.W. Banda M.S. Tuttle L.E. Selma Data processing of urine chromatograms for the clinical management of melanoma Computers Biomed Res 13 1980 549 566
29. M.C. Goodall H. Alton Metabolism of 3,4-dihydroxyphenylalanine (L-dopa) in human subjects Biochem Pharmacol 21 1972 2401 2408
30. S. Ito T. Kato K. Maruta K. Jimbow K. Fujita “Total” acidic metabolites of catecholamines in urine as determined by dydrolysis with hydriodic acid and liquid chromatography: application to patients with neuroblastoma and melanoma Clin Chem 31 1985 1185 1188
31. G. Agrup P. Agrup T. Andersson L. Hafstrom C. Hansson S. Jacobsson P.-E. Jönsson H. Rorsman A.-M. Rosengren E. Rosengren 5 years’ experience of 5-S-cysteinyldopa in melanoma diagnosis Acta Derm Venereol (Stockh) 59 1979 381 388
32. C. Hansson L.E. Edholm G. Agrup H. Rorsman A.M. Rosengren E. Rosengren The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography Clin Chim Acta 88 1978 419 427
33. L.L. Peterson W.R. Woodward W.S. Fletcher M. Palmquist M.A. Tucker A. Ilias Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects J Am Acad Dermatol 19 1988 509 511
34. S. Pavel H. Elzinga F.A.J. Muskiet J.M. Smit N.M. Mulder K.H. Scharaffordt Eumelanin-related indolic compounds in the urine of treated melanoma patients J Clin Chem Clin Biochem 24 1986 167 173
35. K. Yamada K. Jimbow S. Ito Measurement of eumelanin precursor in the urine as a new marker for detection of occult melanoma (abstr) Clin Res 37 1989 355A
36. H. Hara K. Yamada K. Jimbow High serum level of eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a new prognostic marker for malignant melanoma (abstr) J Invest Dermatol 96 4 1991 549A
37. K. Wakamatsu S. Ito K. Fujita Production, circulation and excretion of melanin-related metabolites in B-16 melanoma-bearing mice Acta Derm Venereol (Stockh) 70 1990 367 372
38. Y. Akutsu K. Jimbow Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against melanosomal fraction of human malignant melanoma Cancer Res 46 1986 2906 2911
39. K. Maeda K. Jimbow Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes Cancer 59 1987 415 423
40. K. Jimbow T. Horikoshi H. Takahashi Y. Akutsu K. Maeda Fine structural and immunohistochemical properties of dysplastic melanocytic nevus J Invest Dermatol 92 1989 304S 309S
41. K. Maeda K. Yamada K. Jimbow Development of MoAb HMSA-3 and HMSA-4, against human melanoma melanosomes and their reactivities on formalin-fixed melanoma tissues J Invest Dermatol 89 1987 588 593
42. J. Der K. Jimbow W. Dixon A melansomal antigen, HMSA-5, as marker of melanocyte differentiation and transformation (abstr). 2nd International Conference of Melanoma, October 16–19, 1989 (Venice). Proc 2nd International Conference on Melanoma 214 1989
43. K. Jimbow L. Andreassi R. Halaban A. Houghton P. Parsons G. Lipkin Growth factors and regulators of malignant melanoma O. Cascinelli M. Santinami U. Veronesi Malignant Melanoma 1990 Masson Milan 25 38
44. K. Jimbow H. Chen Identification of a new melanosomal glycoprotein gp41 (HMSA-6), biosynthesis, glycosylation and distinctness from HMSA 1–5 (abstr) J Invest Dermatol 96 1991 631A
45. H. Chen K. Jimbow Distinction of new 37 kDa HMSA-6 glycoprotein unique to human melanosomes as compared to melansomes’ common antigen (HMSA-5 American Association for Cancer Research, 82nd Annual Meeting (Houston) May 15–18 1991
46. Y. Akutsu K. Jimbow Immunoelectron microscopic demonstration of human melanosome associated antigen (HMSA) on melanoma cells; comparison with tyrosinase distribution J Invest Dermatol 90 1988 179 185
47. K. Jimbow T.B. Fitzpatrick Characterization of a new melanosomal structural component – the vesiculoglobular body – by conventional transmission, high-voltage, and scanning electron microscopy J Ultra-struct Mol Struct Res 48 1974 269 283
48. S. Vijayasaradhi B. Bouchard A.N. Houghton The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product J Exp Med 171 1990 1375 1380
49. S. Vijayasaradhi P.M. Doskoch A.N. Houghton Biosynthesis and intracellular movement of melanosomal membrane glycoprotein gp75, the human b (brown) locus product Exp Cell Res 196 1991 233 240
50. K. Jimbow G.J. Lauzon Malignant melanoma: a life threatening skin cancer affecting young people – its diagnosis and management Ann R Coll Phys Surg 23 1990 105 110
51. H.K. Koh Cutaneous melanoma New Engl J Med 325 1991 171 182
52. M. Herlyn W.H. Clark U. Rodeck M.L. Mancianti J. Jambrosic H. Koprowski Biology of tumor progression in human melanocytes Lab Invest 56 1987 461 474
53. M. Herlyn M.L. Mancianti J. Jambrosic J.B. Bolen H. Koprowski Regulatory factors that determine growth and phenotype of normal human melanocytes Exp Cell Res 179 1988 322 331
54. A.N. Houghton F.Y. Real L.J. Davis C. Cordon-Cardo L.J. Old Phenotypic heterogenicity of melanoma; relation to the differentiation program of melanoma cells J Exp Med 165 1987 812 829
55. T. Salopek K. Jimbow Dysplastic melanocytic nevus: immunohistochemical heterogeneity by melanosomal markers Am J Dermatopathol 13 1991 130 136
56. S. Ito U. Fujita Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography K. Jimbow Structure and Function of Melanin Vol. 3 1985 Fuji-Shoin Sapporo 19 29
57. K. Jimbow O. Ishida H. Takahashi S. Ito Hair color and type of melanogenesis in human hair: characterization based on analysis of eumelanin and pheomelanin, and ultrastructural analysis of melanoma structure K. Jimbow Structured Function of Melanin Vol. 1 1984 Fuji-Shoin Sapporo 26 36